K-V Pharmaceutical announced that the FDA has granted approval for the return of Micro-K (potassium chloride) to the market. K-V Pharmaceutical expects that initial shipments of its Micro-K 10mEq and Micro-K 8mEq will begin this week.

Micro-K in indicated for the treatment and prevention of hypokalemia.

For more information call (800) 567-7676 or visit www.kvpharmaceutical.com.